Pfizer Inc. on Tuesday reported better-than-expected results for its first quarter and raised its guidance for the year as both new and established product lines showed revenue growth.
Last year, General Motors Co. GM -0.16 % fended off a group of activist investors with the help of an esoteric financial metric to which it had previously paid little heed.
Specialty drugs and retail expansions boosted CVS Health's first-quarter revenue by 18.9 percent, helping to offset higher costs and push results above Wall Street expectations.
(Adds details, shares). May 3 U.S. agribusiness Archer Daniels Midland Co reported a 53.3 percent decline in quarterly profit, weighed down by slumping energy prices and lower U.S.
Mylan MYL 2.40 % NV reported that its profit slipped in the latest quarter as expenses ticked up, though the pharmaceutical company's adjusted profit came in above analysts' projections.